Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$715K Buy
3,232
+58
+2% +$12.7K 0.03% 353
2026
Q2
$619K Buy
3,174
+1,069
+51% +$222K 0.02% 374
2026
Q1
$473K Buy
2,105
+7
+0.3% +$1.74K 0.03% 379
2025
Q4
$505K Sell
2,098
-4
-0.2% -$1.02K 0.04% 354
2025
Q3
$575K Buy
+2,102
New +$574K 0.05% 359

Other funds holding RMD

Tema ETFs's RMD Position: Q3 2026 in Review

Tema ETFs increased its ResMed (RMD) stake by 1.8% in Q3 2026, buying an estimated $12.7K and bringing the position to 3,232 shares worth $715K. The position accounts for 0.03% of the portfolio, ranked #353.

Tema ETFs first reported a position in RMD in Q3 2025 and has held it in 5 quarters since. 145 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Tema ETFs held 3,232 shares of ResMed worth $715K as of Q3 2026.
  • Tema ETFs bought 58 ResMed shares in Q3 2026, an estimated $12.7K.
  • ResMed made up 0.03% of Tema ETFs's portfolio in Q3 2026, its #353 holding.
  • Tema ETFs first reported a position in ResMed in Q3 2025 and has held it in 5 quarters since.
  • 145 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.